- Lobbying
- Lobbying by Akebia Therapeutics Inc
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Melissa Bartlett | Privacy Program Specialist, U.S. Department of Health and Human Services, Office of the Secretary, Office for Civil Rights Counsel, U.S. House of Representatives, Committee on Energy and Commerce |
Anna Weinstein | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Budget
Registration
Issue(s) they said they’d lobby about: Issues pertaining to chronic kidney disease, generally; and issues specifically relating to end-stage renal disease (ESRD) drugs, innovation, and reimbursement (including Medicare coverage and reimbursement issues)..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate